We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

DexCom’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the ...

It is hoped the "groundbreaking" device will help improve treatment options for people with eczema, as STV Reporter Amie Flett reports. For years, people living with ...

The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, ...

Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as ...

Thur 2 Oct 2.13pm • Scientists at Heriot-Watt University in Edinburgh believe they've developed new technology that could revolutionise how eczema is diagnosed and treated.

You can reset a Facebook Portal to its factory settings manually on the device itself or through the touchscreen's settings ...

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...